David P E Satijn

USPTO Granted Patents = 5 (Patent Applications = 1)

CIPO Patents = 1

EPO Patents = 1 (Patent Applications = 1)

Average Co-Inventor Count = 5.5

ph-index = 3

Forward Citations = 32(Granted Patents)

Company Filing History:

where one patent can have more than one assignee

Years Active: 2007-2025

Loading Chart...

5 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12398214 - Binding agents binding to EpCAM and CD137 (2025-08-26),

2. 9714297 - Human antibodies against tissue factor and methods of use thereof (2017-07-25),

3. 9150658 - Human antibodies against tissue factor and methods of use thereof (2015-10-06),

4. 7794977 - Means and methods for regulating gene expression (2010-09-14),

5. 7267965 - Means and methods for regulating gene expression (2007-09-11),

Title: The Innovative Contributions of David P E Satijn

Introduction

David P E Satijn is a notable inventor based in Nieuwegein, Netherlands. He has made significant contributions to the field of biotechnology, particularly in the development of binding agents and antibodies that have potential applications in cancer treatment. With a total of five patents to his name, Satijn's work reflects a commitment to advancing medical science.

Latest Patents

Among his latest patents is a binding agent that targets EpCAM and CD137. This invention is particularly useful for treating or preventing tumors and cancers, as well as preventing their progression. Another significant patent involves isolated human monoclonal antibodies that bind to human tissue factor (TF). This patent also includes related antibody-based compositions and pharmaceutical formulations, which can be utilized in therapeutic and diagnostic methods.

Career Highlights

David P E Satijn has worked with prominent companies in the biotechnology sector, including Genmab and Chromagenics. His experience in these organizations has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Some of his notable coworkers include Arie Pieter Otte and Arthur Leo Kruckeberg. Their collaborative efforts have likely enhanced the innovative outcomes of their projects.

Conclusion

David P E Satijn's contributions to biotechnology through his patents and collaborations highlight his role as a significant inventor in the field. His work continues to pave the way for advancements in cancer treatment and therapeutic methods.

This text is generated by artificial intelligence and may not be accurate.